Sonoma Pharmaceuticals, Inc. (34)

Browse by Contract Category

Contracts

SONOMA PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM AND STOCK OWNERSHIP GUIDELINES Revised by the Board of Directors on December29, 2022 (Filed With SEC on December 30, 2022)
At-The-Market Offering Agreement, by and between the Company and Ladenburg Thalmann & Co. Inc., dated December 23, 2022 (Filed With SEC on December 23, 2022)
Amended and Restated Employment Agreement by and between the Company and Bruce Thornton, dated July 22, 2022 (Filed With SEC on July 22, 2022)
Exclusive License and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Anlicare International dated January 18, 2022 (Filed With SEC on January 20, 2022)
Non-Exclusive Distribution and Supply Agreement between Sonoma Pharmaceuticals, Inc. and Salus Medical, LLC dated January 19, 2022 (Filed With SEC on January 20, 2022)
Woodstock Lease Agreement between the Company and Fowler Crossing Partners, LP, dated October 1, 2018 (Filed With SEC on July 10, 2020)
Offer letter to Chad White dated September 8, 2022 (Filed With SEC on October 7, 2022)
Amended and Restated Employment Agreement by and between the Company and Amy Trombly, dated July 22, 2022 (Filed With SEC on July 22, 2022)
Exclusive License and Distribution Agreement between the Company and Dyamed Biotech Pte, Ltd., dated November 4, 2021 (Filed With SEC on November 9, 2021)
At-The-Market Offering Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated July 30, 2021 (Filed With SEC on July 30, 2021)
Employment Agreement by and between the Company and Bruce Thornton, dated July 1, 2021 (Filed With SEC on July 6, 2021)
Employment Agreement by and between the Company and Jerry Dvonch, dated July 1, 2021 (Filed With SEC on July 6, 2021)
Employment Agreement by and between the Company and Amy Trombly, dated July 1, 2021 (Filed With SEC on July 6, 2021)
Exclusive Supply and Distribution Agreement between the Company and EMC Pharma, LLC, dated March 26, 2021 (Filed With SEC on March 31, 2021)
Addendum to Employment Agreement with Amy Trombly, dated January 4, 2020 (Filed With SEC on January 8, 2021)
Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Gabriel Science, LLC, effective December 14, 2020 (Filed With SEC on December 17, 2020)
Exclusive Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Crown Laboratories, Inc., effective December 4, 2020 (Filed With SEC on December 10, 2020)
Amendment No. 1 to the Consulting Agreement between the Company and TechCXO, LLC dated September 10, 2020 (Filed With SEC on September 11, 2020)
Offer letter J. Dvonch dated August 10, 2020 (Filed With SEC on September 11, 2020)
Licensing Agreement between Sonoma Pharmaceuticals, Inc. and Microsafe Group, effective July 27, 2020 (Filed With SEC on August 6, 2020)
Amendment No. 9 to Office Lease Agreement between the Company and SSCOP Properties LLC, dated June 20, 2020 (Filed With SEC on July 10, 2020)
Asset Purchase Agreement between Sonoma Pharmaceuticals, Inc. and Infinity Labs SD Inc., dated June 24, 2020 (Filed With SEC on June 29, 2020)
Consulting Agreement between the Company and Dr. Robert Northey, dated May 30, 2020 (Filed With SEC on June 4, 2020)
Separation and Release Agreement between the Company and Dr. Robert Northey, dated May 29, 2020 (Filed With SEC on June 4, 2020)
License, Distribution and Supply Agreement by and between Sonoma Pharmaceuticals, Inc. and Brill International, S.L. dated May 19, 2020 (Filed With SEC on May 26, 2020)
Mutual Separation and Release Agreement between the Company and John Dal Poggetto, dated April 14, 2020 (Filed With SEC on April 20, 2020)
Consulting Agreement between the Company and TechCXO, LLC effective April 14, 2020 (Filed With SEC on April 20, 2020)
Asset Purchase Agreement dated February 21, 2020, between Sonoma Pharmaceuticals, Inc. and Microsafe Group, DMCC (Filed With SEC on February 27, 2020)
Employment Agreement between Sonoma Pharmaceuticals, Inc. and Amy Trombly, effective December 26, 2019 (Filed With SEC on December 31, 2019)
Form of Placement Agent Warrant granted to Dawson James Securities, Inc. in connection with the November 2019 public offering (Filed With SEC on November 29, 2019)
Placement Agency Agreement entered into by and between Sonoma Pharmaceuticals, Inc. and Dawson James Securities, Inc., as representative, dated November 26, 2019 (Filed With SEC on November 29, 2019)
Employment Agreement between Sonoma Pharmaceuticals, Inc. and Amy Trombly, effective September 25, 2019 (Filed With SEC on October 15, 2019)
Employment Agreement between Sonoma Pharmaceuticals, Inc. and John Dal Poggetto, effective September 25, 2019 (Filed With SEC on October 15, 2019)
Asset Purchase Agreement dated May 14, 2019, between Sonoma Pharmaceuticals, Inc. and Petagon, Ltd (Filed With SEC on May 22, 2019)